Kodiak Venture Partners III Lp - Jul 24, 2023 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role: Other*
Signature: Kodiak Venture Partners III, L.P. By: Kodiak Ventures Management III, L.P., its general partner By: Kodiak Ventures Management III (GP), LLC, its general partner By: /s/ David Furneaux Title: Manager
Stock symbol: GRNA
Transactions as of: Jul 24, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/27/2023, 10:55 AM
Previous filing: Jul 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRNA	Common Stock, par value $0.0001 per share	Other		-9.81M	-100%		0	Jul 24, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kodiak Venture Partners III Lp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Kodiak Venture Partners III, L.P. held 9,573,157 of these shares, and Kodiak III Entrepreneurs Fund, L.P. held 236,741 of these shares.
F2	Pursuant to the Contribution and Exchange Agreement dated May 29, 2023 between GreenLight Biosciences Parent, PBC ("Parent") and each of Kodiak Venture Partners III, L.P. and Kodiak III Entrepreneurs Fund, L.P., each of Kodiak Venture Partners III, L.P. and Kodiak III Entrepreneurs Fund, L.P. contributed its respective shares of common stock of the Issuer to Parent in exchange for shares of Series A-2 Preferred Stock, par value $0.0001 per share, of Parent in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated May 29, 2023, by and among Issuer, Parent and SW MergerCo, Inc. ("Merger Sub") on July 24, 2023, pursuant to which Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent.

Content

Kodiak Venture Partners III, L.P. held 9,573,157 of these shares, and Kodiak III Entrepreneurs Fund, L.P. held 236,741 of these shares.

Pursuant to the Contribution and Exchange Agreement dated May 29, 2023 between GreenLight Biosciences Parent, PBC ("Parent") and each of Kodiak Venture Partners III, L.P. and Kodiak III Entrepreneurs Fund, L.P., each of Kodiak Venture Partners III, L.P. and Kodiak III Entrepreneurs Fund, L.P. contributed its respective shares of common stock of the Issuer to Parent in exchange for shares of Series A-2 Preferred Stock, par value $0.0001 per share, of Parent in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated May 29, 2023, by and among Issuer, Parent and SW MergerCo, Inc. ("Merger Sub") on July 24, 2023, pursuant to which Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent.

Remarks:

The Reporting Persons may be deemed to be members of a "group" (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934 of persons which, in the aggregate, beneficially owned more than 10% of the Issuer's Common Stock. The filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons was a beneficial owner of more than 10% of any class of securities of the Issuer for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.